/Home/Asia-Pacific/Intellectual Property in Asia-Pacific Region/Ropes & Gray LLP
View profile of Ropes & Gray LLP
Department profile
Ropes & Gray LLP
Department profile | Ropes & Gray LLP
Intellectual Property

About

Provided by Ropes & Gray LLP

For over 150 years, our global intellectual property group has provided clients across the world with a broad spectrum of IP services, handling cutting-edge cases, transactions and other strategic matters from six offices in key cities across the United States – Boston, Chicago, New York, San Francisco, Silicon Valley, and Washington, D.C. and four international offices in London, Shanghai, Tokyo, and Seoul. On the ground across three different continents, our intellectual property professionals provide clients with around-the-clock, top-tier IP support on an international stage.

To learn more about our practice, please visit: https://www.ropesgray.com/practices/intellectual-property.aspx

Chambers Review

Provided by Chambers

Intellectual Property - Asia-Pacific Region

3
Band 3

What the Team is Known For

Ropes & Gray houses a talented group with a focus on IP litigation between China, South Korea and the USA. It has key strengths in patent infringement litigation for technology and pharmaceutical companies in addition to being well-versed in copyright and trade mark issues. Also, the firm handles transactional matters involving a range of IP assets. The team has specialist knowledge of the pharmaceutical and semiconductor industries. It leverages support from teams in Boston, New York, Silicon Valley and Washington, DC to coordinate mandates for leading US-headquartered corporates.

Notable practitioners

The key contacts for the firm's IP offering are Katherine Wang in Singapore and Eric Wu for the firm's Hong Kong office.

Work Highlights

  • Ropes & Gray represented J-Pharma in an agreement with Georgetown University granting an exclusive worldwide licence to use patents and patent applications held by Georgetown University for an amino acid transporter inhibitor for the treatment of inflammatory diseases of the central nervous system.